RecruitingNCT06169033

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)


Sponsor

China-Japan Friendship Hospital

Enrollment

800 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.


Eligibility

Min Age: 16 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is using specialized analysis of CT scan images of belly fat (called radiomics) to predict how well weight-loss surgery will work for patients with obesity and type 2 diabetes. Researchers want to find out if the type and location of fat in the body can help predict surgical outcomes. **You may be eligible if...** - You have a BMI greater than 27.5 kg/m² - You have type 2 diabetes - You are scheduled to have bariatric (weight-loss) surgery **You may NOT be eligible if...** - You do not have an abdominal CT scan available - You are not having sleeve gastrectomy or Roux-en-Y gastric bypass surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Yuntao Nie

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06169033


Related Trials